Three senior executives at Tilray Brands, Inc. ($TLRY) purchased shares in separate open-market transactions during the first week of August 2026, according to SEC Form 4 filings. The combined dollar value of the three purchases was $69,225.
Chief Strategy Officer Denise M. Faltischek acquired 2,500 shares at $4.78 per share on August 3, for a total of $11,950. The filing was submitted on August 4 and showed she held 141,285 shares following the transaction. CFO Carl A. Merton bought 10,000 shares at $4.62 per share on August 4, the largest of the three purchases at $46,200. The same-day filing reported post-transaction ownership of 139,753 shares. Global General Counsel Gendel Mitchell purchased 2,500 shares at $4.43 per share on August 6, totaling $11,075. That filing was submitted on August 7, one day after the trade, and showed ownership of 124,883 shares. All three transactions were coded as open-market purchases on Form 4, and each filing was made within one day of the trade date.
The cluster marked the second time in 13 months that multiple Tilray C-suite officers bought shares in close succession. In late July 2025, CEO Irwin D. Simon acquired 165,000 shares at $0.61 per share, CFO Merton bought 33,500 shares at $0.60, and General Counsel Mitchell purchased 6,000 shares at approximately $0.58. Those 2025 purchases totaled roughly $123,540 across the three executives. By August 2026, the stock was trading at levels roughly eight times higher than the prices paid in the July 2025 cluster.
Between the two insider buying episodes, Director David G. Hopkinson sold his entire position of 33,556 shares at $6.94 per share on April 21, 2026, for a total of $232,879. That sale was the only open-market insider transaction on Tilray stock recorded between the July 2025 cluster and the August 2026 cluster, and it took place at a price roughly 50 percent above where the stock traded during the August purchases.
$TLRY shares closed at $4.44 on August 6, the date of Mitchell's purchase. During the two weeks preceding the cluster, the stock traded in a range of $3.67 to $4.94, with heavier volume days arriving at the end of July as the price moved from the $3.90 area toward the mid-$4.00s.
Tilray Brands operates in the pharmaceuticals and cannabis sectors with a market capitalization of approximately $605 million as of early August 2026. The three insiders involved in the cluster—the chief strategy officer, chief financial officer, and general counsel—held a combined 405,921 shares following the reported purchases.
No members of Congress reported transactions in $TLRY stock during 2026. The most recent congressional trades in Tilray on record date to 2021 and 2022, when Representative Brian Mast (Republican, Florida) and Representative John A. Yarmuth (Democrat, Kentucky) made a series of purchases and sales.